Agilent's 2012 Q1 revenue increased by 8% to US$1.64 billion

On February 15, 2012, Agilent Technologies announced its financial report for the first quarter of fiscal 2012 (as of January 31, 2012).

Financial report data show that revenue for the first quarter of fiscal year 2012 was US$1.64 billion, an increase of 8% over the same period of last year, in which the life sciences business performed outstandingly, with an income of US$461 million, an increase of 14% compared to the same period of last year; and chemical analysis business income of 396 million yuan. The U.S. dollar increased by 13% year-on-year; the electronic measurement service revenue was 778 million U.S. dollars, an increase of 1% year-on-year. In the quarter, orders fell slightly from the same period last year, from 1.63 billion US dollars to 1.62 billion US dollars.

In a conference call after the financial report, Bill Sulliva, president and CEO of Agilent, said, “All major markets continue to perform strongly, environmental market revenue increased by 16% year-on-year, food market revenue increased by 14%, and petrochemical market grew by 14%. The biotechnology market grew by 18% year-on-year, and academic/government market revenues increased by 7%.”

During the quarter, Agilent’s R&D investment increased to US$162 million, an increase of 2% compared to US$159 million in the same period last year. During the quarter, the company earned $230 million, or $0.65 per share.

This quarter, Agilent had $3.66 billion in cash and cash equivalents.

Agilent said that revenue for the second quarter of fiscal 2012 is expected to be between $1.7 billion and $1.72 billion.